222 related articles for article (PubMed ID: 34118772)
81. Survival Impact of Surgical Resection in Locally Advanced T4b Oral Squamous Cell Carcinoma.
Gangopadhyay A; Bhatt S; Nandy K; Rai S; Rathod P; Puj KS
Laryngoscope; 2021 Jul; 131(7):E2266-E2274. PubMed ID: 33459389
[TBL] [Abstract][Full Text] [Related]
82. Survival outcomes after treatment of cancer of the oral cavity (1985-2015).
Zanoni DK; Montero PH; Migliacci JC; Shah JP; Wong RJ; Ganly I; Patel SG
Oral Oncol; 2019 Mar; 90():115-121. PubMed ID: 30846169
[TBL] [Abstract][Full Text] [Related]
83. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135
[TBL] [Abstract][Full Text] [Related]
84. Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1.
Soulières D; Licitra L; Mesía R; Remenár É; Li SH; Karpenko A; Chol M; Wang YA; Solovieff N; Bourdeau L; Sellami D; Faivre S
Clin Cancer Res; 2018 Jun; 24(11):2505-2516. PubMed ID: 29490986
[No Abstract] [Full Text] [Related]
85. Nomogram prediction for survival of patients with oral cavity squamous cell carcinoma.
Bobdey S; Balasubramaniam G; Mishra P
Head Neck; 2016 Dec; 38(12):1826-1831. PubMed ID: 27227458
[TBL] [Abstract][Full Text] [Related]
86. Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the oral cavity and tongue base.
Rubio Bueno P; Naval Gias L; García Delgado R; Domingo Cebollada J; Díaz González FJ
Head Neck; 1998 May; 20(3):232-9. PubMed ID: 9570629
[TBL] [Abstract][Full Text] [Related]
87. Deep learning analysis using FDG-PET to predict treatment outcome in patients with oral cavity squamous cell carcinoma.
Fujima N; Andreu-Arasa VC; Meibom SK; Mercier GA; Salama AR; Truong MT; Sakai O
Eur Radiol; 2020 Nov; 30(11):6322-6330. PubMed ID: 32524219
[TBL] [Abstract][Full Text] [Related]
88. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
89. The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinoma.
Nauta IH; Heideman DAM; Brink A; van der Steen B; Bloemena E; Koljenović S; Baatenburg de Jong RJ; Leemans CR; Brakenhoff RH
Int J Cancer; 2021 Jul; 149(2):420-430. PubMed ID: 33634865
[TBL] [Abstract][Full Text] [Related]
90. Tumor-related leukocytosis predictive of recurrence and survival in patients with oral cavity squamous cell carcinoma.
Roh JL; Lee H; Choi SH; Nam SY; Kim SY
Oral Dis; 2019 Sep; 25(6):1511-1518. PubMed ID: 31165559
[TBL] [Abstract][Full Text] [Related]
91. Comparing prognostic utility between the 8th edition of TNM staging system and the lymph node ratio for oral squamous cell carcinoma.
Beltramini GA; Belloni LM; Fusco N; Sacconi A; Muti P; Baj A; Bolzoni AR; Giannì AB
Head Neck; 2021 Oct; 43(10):2876-2882. PubMed ID: 34115912
[TBL] [Abstract][Full Text] [Related]
92. High-Risk
Sandulache VC; Michikawa C; Kataria P; Gleber-Netto FO; Bell D; Trivedi S; Rao X; Wang J; Zhao M; Jasser S; Myers JN; Pickering CR
Clin Cancer Res; 2018 Apr; 24(7):1727-1733. PubMed ID: 29330202
[No Abstract] [Full Text] [Related]
93. Neoadjuvant immunoradiotherapy in patients with locally advanced oral cavity squamous cell carcinoma: a retrospective study.
Shen P; Qiao B; Jin N; Wang S
Invest New Drugs; 2022 Dec; 40(6):1282-1289. PubMed ID: 35972629
[TBL] [Abstract][Full Text] [Related]
94. Impact of p16-overexpression on overall and progression-free survival outcomes in oral cavity squamous cell carcinomas: A semi-national, population-based study.
Schneider K; Jakobsen KK; Jensen JS; Wessel I; Christensen A; Specht L; Lelkaitis G; Mirian C; Buchwald CV; Grønhøj C
Oral Oncol; 2020 Dec; 111():105031. PubMed ID: 33069060
[TBL] [Abstract][Full Text] [Related]
95. 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment.
Guerrero-Preston R; Godoy-Vitorino F; Jedlicka A; Rodríguez-Hilario A; González H; Bondy J; Lawson F; Folawiyo O; Michailidi C; Dziedzic A; Thangavel R; Hadar T; Noordhuis MG; Westra W; Koch W; Sidransky D
Oncotarget; 2016 Aug; 7(32):51320-51334. PubMed ID: 27259999
[TBL] [Abstract][Full Text] [Related]
96. Impact of pretherapeutic neutrophil-to-lymphocyte ratio, serum albumin, body-mass index, and advanced lung cancer inflammation index on clinical outcome in sinonasal squamous cell carcinoma.
Brkic FF; Kadletz L; Jank B; Mayer C; Heiduschka G; Brunner M
J Craniomaxillofac Surg; 2020 Jan; 48(1):33-37. PubMed ID: 31810849
[TBL] [Abstract][Full Text] [Related]
97. Overexpression of cysteine-glutamate transporter and CD44 for prediction of recurrence and survival in patients with oral cavity squamous cell carcinoma.
Lee JR; Roh JL; Lee SM; Park Y; Cho KJ; Choi SH; Nam SY; Kim SY
Head Neck; 2018 Nov; 40(11):2340-2346. PubMed ID: 30303590
[TBL] [Abstract][Full Text] [Related]
98. The role of the genomic mutation signature and tumor mutation burden on relapse risk prediction in head and neck squamous cell carcinoma after concurrent chemoradiotherapy.
Wang HC; Moi SH; Chan LP; Wu CC; Du JS; Liu PL; Chou MC; Wu CW; Huang CJ; Hsiao HH; Pan MR; Chen LT
Exp Mol Med; 2023 May; 55(5):926-938. PubMed ID: 37121970
[TBL] [Abstract][Full Text] [Related]
99. Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.
Noble AR; Greskovich JF; Han J; Reddy CA; Nwizu TI; Khan MF; Scharpf J; Adelstein DJ; Burkey BB; Koyfman SA
Anticancer Res; 2016 Feb; 36(2):785-92. PubMed ID: 26851040
[TBL] [Abstract][Full Text] [Related]
100. Perineural invasion in oral squamous cell carcinoma: Incidence, prognostic impact and molecular insight.
Alkhadar H; Macluskey M; White S; Ellis I
J Oral Pathol Med; 2020 Nov; 49(10):994-1003. PubMed ID: 32533593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
